Is the risk of substantial LVSI in stage I endometrial cancer similar to PORTEC in the North American population? – A single-institution study

Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial

Carien L. Creutzberg, W L van Putten, P. Koper et al. · The Lancet · 2000 · 1.8K citations

Medicine, Oncology, Surgery +11

A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study

Henry Keys, James A. Roberts, Virginia L. Brunetto et al. · Gynecologic Oncology · 2004 · 1.7K citations

Medicine, Oncology, Surgery +14

Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A gynecologic oncology group study

C.Paul Morrow, Brian N. Bundy, Robert J. Kurman et al. · Gynecologic Oncology · 1991 · 1.3K citations

Medicine, Gynecology, Oncology +17

Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial

Hein Putter, IM Jürgenliemk-Schulz, JJ Jobsen et al. · The Lancet · 2010 · 1.1K citations

Medicine, Oncology, Radiation Oncology +14

A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study

Emma Rossi, Lynn D. Kowalski, Jennifer Scalici et al. · The Lancet Oncology · 2017 · 911 citations

Medicine, Oncology, Surgery +17